BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 15061701)

  • 1. Role of phosphatidylinositol-3 kinase in regulation of differential sensitivity of melanoma cells to antitumor agents. A model for hormone resistance development in tumor cells.
    Krasil'nikov MA; Luzai EV; Scherbakov AM; Shatskaya VA; Shtil AA; Gershtein ES
    Biochemistry (Mosc); 2004 Mar; 69(3):322-30. PubMed ID: 15061701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The molecular mechanism responsible for the adaptation of malignant tumors to hormonal drugs: a role of phophatidylinositol-3-kinase and phosphoinositide-dependent proteins].
    Pavlichenko OV; Shatskaia VA; Luzaĭ EV; Shcherbakov AM; Gershteĭn ES; Krasil'nikov MA
    Vestn Ross Akad Med Nauk; 2004; (12):20-5. PubMed ID: 15678684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transducer and activator of transcription-3 and phosphatidylinositol-3 kinase as coordinate regulators of melanoma cell response to glucocorticoid hormones.
    Krasil'nikov M; Shatskaya V
    J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):369-76. PubMed ID: 12589944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.
    Kang Y; Park MA; Heo SW; Park SY; Kang KW; Park PH; Kim JA
    Biochim Biophys Acta; 2013 Mar; 1830(3):2638-48. PubMed ID: 23246576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of phosphatidylinositol signaling pathway in the development of cross-resistance of tumor cells to hormonal cytostatics and hypoxia.
    Shatskaya VA; Pavlichenko OV; Krasil'nikov MA
    Bull Exp Biol Med; 2007 Feb; 143(2):244-7. PubMed ID: 17970212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition.
    Jiang X; Zhou J; Giobbie-Hurder A; Wargo J; Hodi FS
    Clin Cancer Res; 2013 Feb; 19(3):598-609. PubMed ID: 23095323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of phosphatidylinositol signalling path in developing hormonal resistance in tumor cells].
    Krasil'nikov MA; Shatskaia VA
    Vopr Onkol; 2001; 47(2):218-23. PubMed ID: 11383461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Cytotoxicity of Lenalidomide and Dexamethasone in Mantle Cell Lymphoma via Cereblon-dependent Targeting of the IL-6/STAT3/PI3K Axis.
    Ma J; Wu K; Bai W; Cui X; Chen Y; Xie Y; Xie Y
    EBioMedicine; 2017 Jun; 20():70-78. PubMed ID: 28529032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of phosphatidylinositol 3-kinase in the regulation of cell response to steroid hormones.
    Krasil'nikov MA; Shatskaya VA; Stavrovskaya AA; Erohina M; Gershtein ES; Adler VV
    Biochim Biophys Acta; 1999 Jul; 1450(3):434-43. PubMed ID: 10395954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.
    Böhm M; Schulte U; Funk JO; Raghunath M; Behrmann I; Kortylewski M; Heinrich PC; Kues T; Luger TA; Schwarz T
    J Invest Dermatol; 2001 Jul; 117(1):132-40. PubMed ID: 11442760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.
    Jee SH; Chiu HC; Tsai TF; Tsai WL; Liao YH; Chu CY; Kuo ML
    J Invest Dermatol; 2002 Nov; 119(5):1121-7. PubMed ID: 12445202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.
    Xu Q; Briggs J; Park S; Niu G; Kortylewski M; Zhang S; Gritsko T; Turkson J; Kay H; Semenza GL; Cheng JQ; Jove R; Yu H
    Oncogene; 2005 Aug; 24(36):5552-60. PubMed ID: 16007214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression.
    Ishitsuka A; Fujine E; Mizutani Y; Tawada C; Kanoh H; Banno Y; Seishima M
    Int J Mol Med; 2014 Oct; 34(4):1169-74. PubMed ID: 25109763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM; Bai JY; Yang KX
    IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Potent Inhibitor of Phosphoinositide 3-Kinase (PI3K) and Mitogen Activated Protein (MAP) Kinase Signalling, Quercetin (3, 3', 4', 5, 7-Pentahydroxyflavone) Promotes Cell Death in Ultraviolet (UV)-B-Irradiated B16F10 Melanoma Cells.
    Rafiq RA; Quadri A; Nazir LA; Peerzada K; Ganai BA; Tasduq SA
    PLoS One; 2015; 10(7):e0131253. PubMed ID: 26148186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.
    Penna I; Molla A; Grazia G; Cleris L; Nicolini G; Perrone F; Picciani B; Del Vecchio M; de Braud F; Mortarini R; Anichini A
    Oncotarget; 2016 Jan; 7(4):3947-65. PubMed ID: 26678033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor.
    Caporali S; Alvino E; Lacal PM; Levati L; Giurato G; Memoli D; Caprini E; Antonini Cappellini GC; D'Atri S
    Int J Oncol; 2016 Sep; 49(3):1164-74. PubMed ID: 27572607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells.
    Zingg D; Riesterer O; Fabbro D; Glanzmann C; Bodis S; Pruschy M
    Cancer Res; 2004 Aug; 64(15):5398-406. PubMed ID: 15289348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis.
    Krasilnikov M; Ivanov VN; Dong J; Ronai Z
    Oncogene; 2003 Jun; 22(26):4092-101. PubMed ID: 12821943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.